nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexrazoxane—TOP2A—Fulvestrant—Estradiol—osteoporosis	0.00553	0.336	CbGdCrCtD
Dexrazoxane—TOP2A—Levorphanol—Estradiol—osteoporosis	0.00366	0.222	CbGdCrCtD
Dexrazoxane—TOP2A—Methyltestosterone—Ethinyl Estradiol—osteoporosis	0.00334	0.203	CbGdCrCtD
Dexrazoxane—TOP2A—Norethindrone—Ethinyl Estradiol—osteoporosis	0.00218	0.132	CbGdCrCtD
Dexrazoxane—TOP2A—Levonorgestrel—Ethinyl Estradiol—osteoporosis	0.00173	0.105	CbGdCrCtD
Dexrazoxane—Unspecified disorder of skin and subcutaneous tissue—Risedronate—osteoporosis	0.00135	0.00137	CcSEcCtD
Dexrazoxane—Pruritus—Etidronic acid—osteoporosis	0.00134	0.00137	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Estropipate—osteoporosis	0.00134	0.00137	CcSEcCtD
Dexrazoxane—Decreased appetite—Calcitriol—osteoporosis	0.00134	0.00136	CcSEcCtD
Dexrazoxane—Mental disorder—Conjugated Estrogens—osteoporosis	0.00134	0.00136	CcSEcCtD
Dexrazoxane—Feeling abnormal—Alendronate—osteoporosis	0.00133	0.00136	CcSEcCtD
Dexrazoxane—Erythema—Conjugated Estrogens—osteoporosis	0.00133	0.00135	CcSEcCtD
Dexrazoxane—Malnutrition—Conjugated Estrogens—osteoporosis	0.00133	0.00135	CcSEcCtD
Dexrazoxane—Loss of consciousness—Pamidronate—osteoporosis	0.00133	0.00135	CcSEcCtD
Dexrazoxane—Dry mouth—Risedronate—osteoporosis	0.00133	0.00135	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Alendronate—osteoporosis	0.00132	0.00135	CcSEcCtD
Dexrazoxane—Infection—Ethinyl Estradiol—osteoporosis	0.00132	0.00135	CcSEcCtD
Dexrazoxane—Cough—Pamidronate—osteoporosis	0.00132	0.00134	CcSEcCtD
Dexrazoxane—Pain—Calcitriol—osteoporosis	0.00132	0.00134	CcSEcCtD
Dexrazoxane—Constipation—Calcitriol—osteoporosis	0.00132	0.00134	CcSEcCtD
Dexrazoxane—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.00131	0.00133	CcSEcCtD
Dexrazoxane—Urticaria—Estropipate—osteoporosis	0.00131	0.00133	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Raloxifene—osteoporosis	0.0013	0.00132	CcSEcCtD
Dexrazoxane—Diarrhoea—Etidronic acid—osteoporosis	0.0013	0.00132	CcSEcCtD
Dexrazoxane—Abdominal pain—Estropipate—osteoporosis	0.0013	0.00132	CcSEcCtD
Dexrazoxane—Body temperature increased—Estropipate—osteoporosis	0.0013	0.00132	CcSEcCtD
Dexrazoxane—Feeling abnormal—Ibandronate—osteoporosis	0.0013	0.00132	CcSEcCtD
Dexrazoxane—Tremor—Zoledronate—osteoporosis	0.0013	0.00132	CcSEcCtD
Dexrazoxane—Skin disorder—Ethinyl Estradiol—osteoporosis	0.00129	0.00132	CcSEcCtD
Dexrazoxane—Infection—Risedronate—osteoporosis	0.00129	0.00131	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Ibandronate—osteoporosis	0.00129	0.00131	CcSEcCtD
Dexrazoxane—Myalgia—Pamidronate—osteoporosis	0.00129	0.00131	CcSEcCtD
Dexrazoxane—Urticaria—Alendronate—osteoporosis	0.00129	0.00131	CcSEcCtD
Dexrazoxane—Ill-defined disorder—Zoledronate—osteoporosis	0.00128	0.0013	CcSEcCtD
Dexrazoxane—Body temperature increased—Alendronate—osteoporosis	0.00128	0.0013	CcSEcCtD
Dexrazoxane—Abdominal pain—Alendronate—osteoporosis	0.00128	0.0013	CcSEcCtD
Dexrazoxane—Shock—Risedronate—osteoporosis	0.00128	0.0013	CcSEcCtD
Dexrazoxane—Anaemia—Zoledronate—osteoporosis	0.00128	0.0013	CcSEcCtD
Dexrazoxane—Nervous system disorder—Risedronate—osteoporosis	0.00127	0.0013	CcSEcCtD
Dexrazoxane—Discomfort—Pamidronate—osteoporosis	0.00127	0.00129	CcSEcCtD
Dexrazoxane—Skin disorder—Risedronate—osteoporosis	0.00126	0.00128	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Calcitriol—osteoporosis	0.00126	0.00128	CcSEcCtD
Dexrazoxane—Body temperature increased—Raloxifene—osteoporosis	0.00126	0.00128	CcSEcCtD
Dexrazoxane—Abdominal pain—Raloxifene—osteoporosis	0.00126	0.00128	CcSEcCtD
Dexrazoxane—Urticaria—Ibandronate—osteoporosis	0.00125	0.00127	CcSEcCtD
Dexrazoxane—Malaise—Zoledronate—osteoporosis	0.00125	0.00127	CcSEcCtD
Dexrazoxane—Body temperature increased—Ibandronate—osteoporosis	0.00125	0.00127	CcSEcCtD
Dexrazoxane—Abdominal pain—Ibandronate—osteoporosis	0.00125	0.00127	CcSEcCtD
Dexrazoxane—Syncope—Zoledronate—osteoporosis	0.00124	0.00126	CcSEcCtD
Dexrazoxane—Leukopenia—Zoledronate—osteoporosis	0.00124	0.00126	CcSEcCtD
Dexrazoxane—Haemoglobin—Estradiol—osteoporosis	0.00123	0.00125	CcSEcCtD
Dexrazoxane—Infection—Pamidronate—osteoporosis	0.00123	0.00125	CcSEcCtD
Dexrazoxane—Urticaria—Calcitriol—osteoporosis	0.00123	0.00125	CcSEcCtD
Dexrazoxane—Haemorrhage—Estradiol—osteoporosis	0.00122	0.00124	CcSEcCtD
Dexrazoxane—Abdominal pain—Calcitriol—osteoporosis	0.00122	0.00124	CcSEcCtD
Dexrazoxane—Body temperature increased—Calcitriol—osteoporosis	0.00122	0.00124	CcSEcCtD
Dexrazoxane—Shock—Pamidronate—osteoporosis	0.00122	0.00124	CcSEcCtD
Dexrazoxane—Loss of consciousness—Zoledronate—osteoporosis	0.00122	0.00124	CcSEcCtD
Dexrazoxane—Nervous system disorder—Pamidronate—osteoporosis	0.00121	0.00123	CcSEcCtD
Dexrazoxane—Thrombocytopenia—Pamidronate—osteoporosis	0.00121	0.00123	CcSEcCtD
Dexrazoxane—Vomiting—Etidronic acid—osteoporosis	0.00121	0.00123	CcSEcCtD
Dexrazoxane—Cough—Zoledronate—osteoporosis	0.00121	0.00123	CcSEcCtD
Dexrazoxane—Oedema peripheral—Estradiol—osteoporosis	0.00121	0.00123	CcSEcCtD
Dexrazoxane—Connective tissue disorder—Estradiol—osteoporosis	0.0012	0.00122	CcSEcCtD
Dexrazoxane—Syncope—Conjugated Estrogens—osteoporosis	0.00119	0.00121	CcSEcCtD
Dexrazoxane—Headache—Etidronic acid—osteoporosis	0.00119	0.00121	CcSEcCtD
Dexrazoxane—Musculoskeletal discomfort—Risedronate—osteoporosis	0.00118	0.0012	CcSEcCtD
Dexrazoxane—Asthenia—Estropipate—osteoporosis	0.00118	0.0012	CcSEcCtD
Dexrazoxane—Anorexia—Pamidronate—osteoporosis	0.00118	0.0012	CcSEcCtD
Dexrazoxane—Myalgia—Zoledronate—osteoporosis	0.00118	0.0012	CcSEcCtD
Dexrazoxane—Insomnia—Risedronate—osteoporosis	0.00118	0.0012	CcSEcCtD
Dexrazoxane—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.00117	0.00119	CcSEcCtD
Dexrazoxane—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.00117	0.00119	CcSEcCtD
Dexrazoxane—Pruritus—Estropipate—osteoporosis	0.00116	0.00118	CcSEcCtD
Dexrazoxane—Discomfort—Zoledronate—osteoporosis	0.00116	0.00118	CcSEcCtD
Dexrazoxane—Asthenia—Alendronate—osteoporosis	0.00116	0.00118	CcSEcCtD
Dexrazoxane—Cough—Conjugated Estrogens—osteoporosis	0.00116	0.00118	CcSEcCtD
Dexrazoxane—Dyspnoea—Risedronate—osteoporosis	0.00116	0.00118	CcSEcCtD
Dexrazoxane—Dry mouth—Zoledronate—osteoporosis	0.00115	0.00117	CcSEcCtD
Dexrazoxane—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.00115	0.00117	CcSEcCtD
Dexrazoxane—Fatigue—Ethinyl Estradiol—osteoporosis	0.00115	0.00117	CcSEcCtD
Dexrazoxane—Pruritus—Alendronate—osteoporosis	0.00115	0.00117	CcSEcCtD
Dexrazoxane—Constipation—Ethinyl Estradiol—osteoporosis	0.00114	0.00116	CcSEcCtD
Dexrazoxane—Cardiac disorder—Estradiol—osteoporosis	0.00114	0.00115	CcSEcCtD
Dexrazoxane—Myalgia—Conjugated Estrogens—osteoporosis	0.00113	0.00115	CcSEcCtD
Dexrazoxane—Asthenia—Ibandronate—osteoporosis	0.00113	0.00115	CcSEcCtD
Dexrazoxane—Nausea—Etidronic acid—osteoporosis	0.00113	0.00115	CcSEcCtD
Dexrazoxane—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.00113	0.00114	CcSEcCtD
Dexrazoxane—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.00113	0.00114	CcSEcCtD
Dexrazoxane—Diarrhoea—Estropipate—osteoporosis	0.00113	0.00114	CcSEcCtD
Dexrazoxane—Gastrointestinal disorder—Risedronate—osteoporosis	0.00112	0.00114	CcSEcCtD
Dexrazoxane—Infection—Zoledronate—osteoporosis	0.00112	0.00114	CcSEcCtD
Dexrazoxane—Fatigue—Risedronate—osteoporosis	0.00112	0.00114	CcSEcCtD
Dexrazoxane—Insomnia—Pamidronate—osteoporosis	0.00112	0.00114	CcSEcCtD
Dexrazoxane—Pruritus—Ibandronate—osteoporosis	0.00112	0.00113	CcSEcCtD
Dexrazoxane—Constipation—Risedronate—osteoporosis	0.00111	0.00113	CcSEcCtD
Dexrazoxane—Pain—Risedronate—osteoporosis	0.00111	0.00113	CcSEcCtD
Dexrazoxane—Angiopathy—Estradiol—osteoporosis	0.00111	0.00113	CcSEcCtD
Dexrazoxane—Shock—Zoledronate—osteoporosis	0.00111	0.00113	CcSEcCtD
Dexrazoxane—Diarrhoea—Alendronate—osteoporosis	0.00111	0.00113	CcSEcCtD
Dexrazoxane—Asthenia—Calcitriol—osteoporosis	0.00111	0.00113	CcSEcCtD
Dexrazoxane—Nervous system disorder—Zoledronate—osteoporosis	0.00111	0.00113	CcSEcCtD
Dexrazoxane—Thrombocytopenia—Zoledronate—osteoporosis	0.0011	0.00112	CcSEcCtD
Dexrazoxane—Mediastinal disorder—Estradiol—osteoporosis	0.0011	0.00112	CcSEcCtD
Dexrazoxane—Dyspnoea—Pamidronate—osteoporosis	0.0011	0.00112	CcSEcCtD
Dexrazoxane—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.0011	0.00112	CcSEcCtD
Dexrazoxane—Somnolence—Pamidronate—osteoporosis	0.0011	0.00112	CcSEcCtD
Dexrazoxane—Skin disorder—Zoledronate—osteoporosis	0.0011	0.00111	CcSEcCtD
Dexrazoxane—Pruritus—Calcitriol—osteoporosis	0.00109	0.00111	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.00109	0.00111	CcSEcCtD
Dexrazoxane—Diarrhoea—Raloxifene—osteoporosis	0.00109	0.00111	CcSEcCtD
Dexrazoxane—Dizziness—Estropipate—osteoporosis	0.00109	0.00111	CcSEcCtD
Dexrazoxane—Alopecia—Estradiol—osteoporosis	0.00108	0.0011	CcSEcCtD
Dexrazoxane—Infection—Conjugated Estrogens—osteoporosis	0.00108	0.0011	CcSEcCtD
Dexrazoxane—Diarrhoea—Ibandronate—osteoporosis	0.00108	0.0011	CcSEcCtD
Dexrazoxane—Anorexia—Zoledronate—osteoporosis	0.00108	0.00109	CcSEcCtD
Dexrazoxane—Decreased appetite—Pamidronate—osteoporosis	0.00107	0.00109	CcSEcCtD
Dexrazoxane—Mental disorder—Estradiol—osteoporosis	0.00107	0.00109	CcSEcCtD
Dexrazoxane—Dizziness—Alendronate—osteoporosis	0.00107	0.00109	CcSEcCtD
Dexrazoxane—Shock—Conjugated Estrogens—osteoporosis	0.00107	0.00109	CcSEcCtD
Dexrazoxane—Gastrointestinal disorder—Pamidronate—osteoporosis	0.00107	0.00108	CcSEcCtD
Dexrazoxane—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.00107	0.00108	CcSEcCtD
Dexrazoxane—Erythema—Estradiol—osteoporosis	0.00107	0.00108	CcSEcCtD
Dexrazoxane—Malnutrition—Estradiol—osteoporosis	0.00107	0.00108	CcSEcCtD
Dexrazoxane—Fatigue—Pamidronate—osteoporosis	0.00107	0.00108	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Risedronate—osteoporosis	0.00106	0.00108	CcSEcCtD
Dexrazoxane—Urticaria—Ethinyl Estradiol—osteoporosis	0.00106	0.00108	CcSEcCtD
Dexrazoxane—Pain—Pamidronate—osteoporosis	0.00106	0.00107	CcSEcCtD
Dexrazoxane—Constipation—Pamidronate—osteoporosis	0.00106	0.00107	CcSEcCtD
Dexrazoxane—Diarrhoea—Calcitriol—osteoporosis	0.00106	0.00107	CcSEcCtD
Dexrazoxane—Skin disorder—Conjugated Estrogens—osteoporosis	0.00106	0.00107	CcSEcCtD
Dexrazoxane—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.00105	0.00107	CcSEcCtD
Dexrazoxane—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.00105	0.00107	CcSEcCtD
Dexrazoxane—Dizziness—Raloxifene—osteoporosis	0.00105	0.00107	CcSEcCtD
Dexrazoxane—Vomiting—Estropipate—osteoporosis	0.00105	0.00106	CcSEcCtD
Dexrazoxane—Dizziness—Ibandronate—osteoporosis	0.00104	0.00106	CcSEcCtD
Dexrazoxane—Anorexia—Conjugated Estrogens—osteoporosis	0.00104	0.00105	CcSEcCtD
Dexrazoxane—Urticaria—Risedronate—osteoporosis	0.00103	0.00105	CcSEcCtD
Dexrazoxane—Headache—Estropipate—osteoporosis	0.00103	0.00105	CcSEcCtD
Dexrazoxane—Vomiting—Alendronate—osteoporosis	0.00103	0.00105	CcSEcCtD
Dexrazoxane—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.00103	0.00105	CcSEcCtD
Dexrazoxane—Abdominal pain—Risedronate—osteoporosis	0.00103	0.00104	CcSEcCtD
Dexrazoxane—Body temperature increased—Risedronate—osteoporosis	0.00103	0.00104	CcSEcCtD
Dexrazoxane—Insomnia—Zoledronate—osteoporosis	0.00102	0.00104	CcSEcCtD
Dexrazoxane—Feeling abnormal—Pamidronate—osteoporosis	0.00102	0.00104	CcSEcCtD
Dexrazoxane—Headache—Alendronate—osteoporosis	0.00101	0.00103	CcSEcCtD
Dexrazoxane—Vomiting—Raloxifene—osteoporosis	0.00101	0.00103	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Pamidronate—osteoporosis	0.00101	0.00103	CcSEcCtD
Dexrazoxane—Dyspnoea—Zoledronate—osteoporosis	0.00101	0.00102	CcSEcCtD
Dexrazoxane—Somnolence—Zoledronate—osteoporosis	0.001	0.00102	CcSEcCtD
Dexrazoxane—Vomiting—Ibandronate—osteoporosis	0.001	0.00102	CcSEcCtD
Dexrazoxane—Tremor—Estradiol—osteoporosis	0.000998	0.00101	CcSEcCtD
Dexrazoxane—Headache—Raloxifene—osteoporosis	0.000998	0.00101	CcSEcCtD
Dexrazoxane—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.00099	0.00101	CcSEcCtD
Dexrazoxane—Ill-defined disorder—Estradiol—osteoporosis	0.000989	0.00101	CcSEcCtD
Dexrazoxane—Headache—Ibandronate—osteoporosis	0.000988	0.001	CcSEcCtD
Dexrazoxane—Insomnia—Conjugated Estrogens—osteoporosis	0.000983	0.000999	CcSEcCtD
Dexrazoxane—Vomiting—Calcitriol—osteoporosis	0.000981	0.000998	CcSEcCtD
Dexrazoxane—Decreased appetite—Zoledronate—osteoporosis	0.000981	0.000997	CcSEcCtD
Dexrazoxane—Nausea—Estropipate—osteoporosis	0.000977	0.000993	CcSEcCtD
Dexrazoxane—Abdominal pain—Pamidronate—osteoporosis	0.000977	0.000993	CcSEcCtD
Dexrazoxane—Body temperature increased—Pamidronate—osteoporosis	0.000977	0.000993	CcSEcCtD
Dexrazoxane—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000974	0.000991	CcSEcCtD
Dexrazoxane—Fatigue—Zoledronate—osteoporosis	0.000973	0.000989	CcSEcCtD
Dexrazoxane—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000969	0.000985	CcSEcCtD
Dexrazoxane—Headache—Calcitriol—osteoporosis	0.000967	0.000983	CcSEcCtD
Dexrazoxane—Somnolence—Conjugated Estrogens—osteoporosis	0.000966	0.000982	CcSEcCtD
Dexrazoxane—Pain—Zoledronate—osteoporosis	0.000965	0.000981	CcSEcCtD
Dexrazoxane—Constipation—Zoledronate—osteoporosis	0.000965	0.000981	CcSEcCtD
Dexrazoxane—Nausea—Alendronate—osteoporosis	0.000962	0.000978	CcSEcCtD
Dexrazoxane—Malaise—Estradiol—osteoporosis	0.000961	0.000977	CcSEcCtD
Dexrazoxane—Asthenia—Ethinyl Estradiol—osteoporosis	0.000956	0.000972	CcSEcCtD
Dexrazoxane—Syncope—Estradiol—osteoporosis	0.000956	0.000972	CcSEcCtD
Dexrazoxane—Nausea—Raloxifene—osteoporosis	0.000946	0.000962	CcSEcCtD
Dexrazoxane—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000945	0.00096	CcSEcCtD
Dexrazoxane—Pruritus—Ethinyl Estradiol—osteoporosis	0.000943	0.000959	CcSEcCtD
Dexrazoxane—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000938	0.000954	CcSEcCtD
Dexrazoxane—Fatigue—Conjugated Estrogens—osteoporosis	0.000937	0.000952	CcSEcCtD
Dexrazoxane—Nausea—Ibandronate—osteoporosis	0.000937	0.000952	CcSEcCtD
Dexrazoxane—Loss of consciousness—Estradiol—osteoporosis	0.000937	0.000952	CcSEcCtD
Dexrazoxane—Asthenia—Risedronate—osteoporosis	0.000932	0.000948	CcSEcCtD
Dexrazoxane—Feeling abnormal—Zoledronate—osteoporosis	0.00093	0.000945	CcSEcCtD
Dexrazoxane—Cough—Estradiol—osteoporosis	0.00093	0.000945	CcSEcCtD
Dexrazoxane—Pain—Conjugated Estrogens—osteoporosis	0.000929	0.000945	CcSEcCtD
Dexrazoxane—Constipation—Conjugated Estrogens—osteoporosis	0.000929	0.000945	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Zoledronate—osteoporosis	0.000923	0.000938	CcSEcCtD
Dexrazoxane—Pruritus—Risedronate—osteoporosis	0.000919	0.000935	CcSEcCtD
Dexrazoxane—Nausea—Calcitriol—osteoporosis	0.000917	0.000932	CcSEcCtD
Dexrazoxane—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000912	0.000927	CcSEcCtD
Dexrazoxane—Myalgia—Estradiol—osteoporosis	0.000907	0.000922	CcSEcCtD
Dexrazoxane—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000901	0.000916	CcSEcCtD
Dexrazoxane—Urticaria—Zoledronate—osteoporosis	0.000896	0.000911	CcSEcCtD
Dexrazoxane—Discomfort—Estradiol—osteoporosis	0.000896	0.000911	CcSEcCtD
Dexrazoxane—Abdominal pain—Zoledronate—osteoporosis	0.000892	0.000907	CcSEcCtD
Dexrazoxane—Body temperature increased—Zoledronate—osteoporosis	0.000892	0.000907	CcSEcCtD
Dexrazoxane—Diarrhoea—Risedronate—osteoporosis	0.000889	0.000904	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000889	0.000903	CcSEcCtD
Dexrazoxane—Dry mouth—Estradiol—osteoporosis	0.000887	0.000902	CcSEcCtD
Dexrazoxane—Asthenia—Pamidronate—osteoporosis	0.000886	0.000901	CcSEcCtD
Dexrazoxane—Dizziness—Ethinyl Estradiol—osteoporosis	0.000881	0.000896	CcSEcCtD
Dexrazoxane—Pruritus—Pamidronate—osteoporosis	0.000874	0.000889	CcSEcCtD
Dexrazoxane—Infection—Estradiol—osteoporosis	0.000864	0.000878	CcSEcCtD
Dexrazoxane—Urticaria—Conjugated Estrogens—osteoporosis	0.000863	0.000878	CcSEcCtD
Dexrazoxane—Dizziness—Risedronate—osteoporosis	0.000859	0.000874	CcSEcCtD
Dexrazoxane—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000859	0.000873	CcSEcCtD
Dexrazoxane—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000859	0.000873	CcSEcCtD
Dexrazoxane—Shock—Estradiol—osteoporosis	0.000856	0.00087	CcSEcCtD
Dexrazoxane—Nervous system disorder—Estradiol—osteoporosis	0.000853	0.000867	CcSEcCtD
Dexrazoxane—Vomiting—Ethinyl Estradiol—osteoporosis	0.000847	0.000862	CcSEcCtD
Dexrazoxane—Diarrhoea—Pamidronate—osteoporosis	0.000845	0.000859	CcSEcCtD
Dexrazoxane—Skin disorder—Estradiol—osteoporosis	0.000845	0.000859	CcSEcCtD
Dexrazoxane—Headache—Ethinyl Estradiol—osteoporosis	0.000835	0.000849	CcSEcCtD
Dexrazoxane—Vomiting—Risedronate—osteoporosis	0.000826	0.00084	CcSEcCtD
Dexrazoxane—Dizziness—Pamidronate—osteoporosis	0.000817	0.000831	CcSEcCtD
Dexrazoxane—Headache—Risedronate—osteoporosis	0.000814	0.000828	CcSEcCtD
Dexrazoxane—Asthenia—Zoledronate—osteoporosis	0.00081	0.000823	CcSEcCtD
Dexrazoxane—Pruritus—Zoledronate—osteoporosis	0.000798	0.000812	CcSEcCtD
Dexrazoxane—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000792	0.000806	CcSEcCtD
Dexrazoxane—Nausea—Ethinyl Estradiol—osteoporosis	0.000792	0.000805	CcSEcCtD
Dexrazoxane—Insomnia—Estradiol—osteoporosis	0.000787	0.0008	CcSEcCtD
Dexrazoxane—Vomiting—Pamidronate—osteoporosis	0.000785	0.000799	CcSEcCtD
Dexrazoxane—Asthenia—Conjugated Estrogens—osteoporosis	0.00078	0.000793	CcSEcCtD
Dexrazoxane—Dyspnoea—Estradiol—osteoporosis	0.000775	0.000788	CcSEcCtD
Dexrazoxane—Headache—Pamidronate—osteoporosis	0.000774	0.000787	CcSEcCtD
Dexrazoxane—Somnolence—Estradiol—osteoporosis	0.000773	0.000786	CcSEcCtD
Dexrazoxane—Diarrhoea—Zoledronate—osteoporosis	0.000772	0.000785	CcSEcCtD
Dexrazoxane—Nausea—Risedronate—osteoporosis	0.000772	0.000785	CcSEcCtD
Dexrazoxane—Pruritus—Conjugated Estrogens—osteoporosis	0.000769	0.000782	CcSEcCtD
Dexrazoxane—Decreased appetite—Estradiol—osteoporosis	0.000756	0.000769	CcSEcCtD
Dexrazoxane—Gastrointestinal disorder—Estradiol—osteoporosis	0.000751	0.000763	CcSEcCtD
Dexrazoxane—Fatigue—Estradiol—osteoporosis	0.00075	0.000762	CcSEcCtD
Dexrazoxane—Dizziness—Zoledronate—osteoporosis	0.000746	0.000759	CcSEcCtD
Dexrazoxane—Constipation—Estradiol—osteoporosis	0.000744	0.000756	CcSEcCtD
Dexrazoxane—Pain—Estradiol—osteoporosis	0.000744	0.000756	CcSEcCtD
Dexrazoxane—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000743	0.000756	CcSEcCtD
Dexrazoxane—Nausea—Pamidronate—osteoporosis	0.000734	0.000746	CcSEcCtD
Dexrazoxane—Dizziness—Conjugated Estrogens—osteoporosis	0.000719	0.000731	CcSEcCtD
Dexrazoxane—Vomiting—Zoledronate—osteoporosis	0.000717	0.000729	CcSEcCtD
Dexrazoxane—Feeling abnormal—Estradiol—osteoporosis	0.000717	0.000729	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Estradiol—osteoporosis	0.000711	0.000723	CcSEcCtD
Dexrazoxane—Headache—Zoledronate—osteoporosis	0.000707	0.000719	CcSEcCtD
Dexrazoxane—Vomiting—Conjugated Estrogens—osteoporosis	0.000691	0.000702	CcSEcCtD
Dexrazoxane—Urticaria—Estradiol—osteoporosis	0.000691	0.000702	CcSEcCtD
Dexrazoxane—Body temperature increased—Estradiol—osteoporosis	0.000687	0.000699	CcSEcCtD
Dexrazoxane—Abdominal pain—Estradiol—osteoporosis	0.000687	0.000699	CcSEcCtD
Dexrazoxane—Headache—Conjugated Estrogens—osteoporosis	0.000681	0.000692	CcSEcCtD
Dexrazoxane—Nausea—Zoledronate—osteoporosis	0.00067	0.000681	CcSEcCtD
Dexrazoxane—Nausea—Conjugated Estrogens—osteoporosis	0.000645	0.000656	CcSEcCtD
Dexrazoxane—Asthenia—Estradiol—osteoporosis	0.000624	0.000634	CcSEcCtD
Dexrazoxane—Pruritus—Estradiol—osteoporosis	0.000615	0.000626	CcSEcCtD
Dexrazoxane—Diarrhoea—Estradiol—osteoporosis	0.000595	0.000605	CcSEcCtD
Dexrazoxane—Dizziness—Estradiol—osteoporosis	0.000575	0.000585	CcSEcCtD
Dexrazoxane—Vomiting—Estradiol—osteoporosis	0.000553	0.000562	CcSEcCtD
Dexrazoxane—Headache—Estradiol—osteoporosis	0.000545	0.000554	CcSEcCtD
Dexrazoxane—Nausea—Estradiol—osteoporosis	0.000517	0.000525	CcSEcCtD
